Overview

Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer

Status:
Recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

Aim of this study is to evaluate if low-dose radiotherapy (LDR) can intensify local effect of a chemotherapy regimen with Gem-based doublets administered sequentially with stereotactic body radiotherapy (SBRT) and to assess the safety and efficacy of this combined treatment on patients affected by locally advanced pancreatic adenocarcinoma (LAPC).

Phase:

N/A

Details

Lead Sponsor:

Azienda Ospedaliera - Universitaria di Modena
Azienda Ospedaliero-Universitaria di Modena

Treatments:

Gemcitabine
Oxaliplatin